## Abstract Forty-eight patients who presented to St. Mark's Hospital, London between 1948 and 1979 with smooth muscle neoplasms of the rectum or anal canal have been reviewed. Twenty-six tumours arose from the muscularis mucosae of the rectum. These lesions were small, asymptomatic and did not rec
Molecular determination of the malignant potential of smooth muscle neoplasms
โ Scribed by Wendy Trzyna; Mary McHugh; Peter McCue; Kirk M. McHugh
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 525 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Background:
The determination of the malignant potential of smooth muscle neoplasms remains ambiguous, and yet has far reaching clinical, therapeutic, and social implications.
Methods:
In this pilot study, the authors examined smooth muscle isoactin gene expression by polymerase chain reaction in a variety of smooth muscle tumors.
Results:
A lack of gamma-smooth muscle isoactin gene expression correlated 100% with a pathologic diagnosis of sarcoma. these results suggest that gamma-smooth muscle isoactin gene expression represents a unique molecular marker of oncogenic transformation.
Conclusions:
Gamma-smooth muscle isoactin gene expression provides a valuable molecular adjunct to the diagnosis of smooth muscle neoplasms.
๐ SIMILAR VOLUMES
Smooth muscle cells squeeze Ihe blood back to your heart, raise the hackles on your neck and change the F-stop of your eyes. The past year has provided penetrating new insights into their mechanism of contraction.
There has been accumulating histological observation of leiomyoma and leiomyosarcoma of the external soft tissue regarding their differential diagnosis. The definitive diagnostic tools have not been established, however, nor have the pathological mechanisms of cell proliferation in these tumors been
## Abstract Prostacyclin (PGI~2~) has been shown to inhibit proliferation in vascular smooth muscle cells. To clarify the underlying molecular mechanism, we investigated the vasoprotection of beraprost (a PGI~2~ agonist) both in vivo and in vitro. Beraprost eliminated increases in proliferation of